Establishment of a Panel of Human Cell Lines to Identify Cellular Receptors Used by to Infect Cells.

Non-pathogenic natural and recombinant strains of human are the subject of ongoing study with some strains having been approved for use as anticancer agents. The efficacy of oncolytic virotherapy depends upon identifying the receptor utilized by a specific strain for cell entry, and the presence of this receptor on the surface of cancer cells. Accordingly, a rapid and straightforward approach to determining the enteroviral receptors is necessary for developing an effective patient-specific, virus-based cancer therapy. To this end, we created a panel of seven lines with double knockouts on the background of the HEK293T cell line, which lacks the gene. In these lines, the main viral receptor genes, including , , , , , , and , were knocked out using the CRISPR/Cas9 system. The panel of lines was validated on twelve different types, providing a basis for studying the molecular mechanisms of enterovirus entry into cells, and for developing new therapeutic strains.